Integra LifeSciences Holdings Cor.../ US4579852082 /
| 2024-04-22 10:00:00 PM | Chg. +0.3000 | Volume | Bid1:00:06 PM | Ask1:00:06 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 28.9800USD | +1.05% | 1.61 mill. Turnover: 31.52 mill. |
24.5500Bid Size: 200 | 34.4100Ask Size: 100 | 2.27 bill.USD | - | 34.09 |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 337.4040 | 287.5290 | 311.7030 | 311.3020 | 340.1990 | ||||||
| Intangible Assets | 1,031.5910 | 989.4360 | 1,145.5730 | 1,126.6090 | 1,067.8330 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 2,445.0720 | 2,377.9340 | 2,628.6670 | 2,728.2600 | 2,723.9520 | ||||||
| Inventories | 316.0540 | 310.1170 | 317.3860 | 324.5830 | 389.6080 | ||||||
| Accounts Receivable | 275.2960 | 225.5320 | 231.8310 | 263.4650 | 259.3270 | ||||||
| Cash and Cash Equivalents | 198.9110 | 470.1660 | 513.4480 | 456.6610 | 276.4020 | ||||||
| Current Assets | 858.1680 | 1,237.2020 | 1,153.7160 | 1,161.4980 | 1,058.0360 | ||||||
| Total Assets | 3,303.2400 | 3,615.1360 | 3,782.3830 | 3,889.7580 | 3,781.9880 | ||||||
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 113.0900 | 54.6080 | 61.8370 | 102.1000 | 92.3260 | ||||||
| Long-term debt | 1,303.0610 | 1,408.2210 | 1,501.1830 | 1,405.1900 | 1,485.0180 | ||||||
| Liabilities to Banks | 1,348.1000 | - | - | - | - | ||||||
| Provisions | 36.6000 | - | - | - | - | ||||||
| Liabilities | 1,886.5040 | 2,100.2690 | 2,097.5790 | 2,085.3550 | 2,194.1040 | ||||||
| Share Capital | .8870 | .8930 | .8960 | .9050 | .9090 | ||||||
| Total Equity | 1,416.7360 | 1,514.8670 | 1,684.8040 | 1,804.4030 | 1,587.8840 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 3,303.2400 | 3,615.1360 | 3,782.3830 | 3,889.7580 | 3,781.9880 | ||||||
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,517.5570 | 1,371.8680 | 1,542.4480 | 1,557.6660 | 1,541.5730 | ||||||
| Depreciation (total) | 109.4620 | 116.0310 | 119.8360 | 118.2990 | 123.5120 | ||||||
| Operating Result | 93.7600 | 151.3700 | 197.2300 | 238.9200 | 111.5260 | ||||||
| Interest Income | -43.1780 | -62.2840 | -43.6580 | -37.6770 | -34.1750 | ||||||
| Income Before Taxes | 60.1040 | 93.5200 | 214.6770 | 213.8940 | 81.0690 | ||||||
| Income Taxes | 9.9030 | -40.3720 | 45.6020 | 33.3440 | 13.3280 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 50.2010 | 133.8920 | 169.0750 | 180.5500 | 67.7410 | ||||||
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 231.4330 | 203.8320 | 312.4270 | 264.4690 | 139.9550 | ||||||
| Cash Flow from Investing Activities | -162.6680 | -68.0730 | -161.4430 | -58.5800 | -94.1780 | ||||||
| Cash Flow from Financing | -8.7660 | 121.6250 | -98.2260 | -251.9530 | -229.9250 | ||||||
| Decrease / Increase in Cash | 60.0730 | 271.2550 | 43.2820 | -56.7870 | -180.2590 | ||||||
| Employees | 4,000 | - | - | - | - | ||||||
